tiprankstipranks
Trending News
More News >
Tonix Pharma (TNXP)
NASDAQ:TNXP
US Market
Advertisement

Tonix Pharma (TNXP) Technical Analysis

Compare
4,930 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Tonix Pharma’s (TNXP) Moving Averages Convergence Divergence (MACD) indicator is -3.37, suggesting Tonix Pharma is a Sell.
Tonix Pharma’s (TNXP) 20-Day exponential moving average is 30.34, while Tonix Pharma’s (TNXP) share price is $26, making it a Sell.
Tonix Pharma’s (TNXP) 50-Day exponential moving average is 34.34, while Tonix Pharma’s (TNXP) share price is $26, making it a Sell.

Tonix Pharma (TNXP) Pivot Points

Sep 22, 2025, 03:46 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
26.52
27.12
27.75
28.35
28.98
29.58
30.21
Fibonacci
27.12
27.59
27.88
28.35
28.82
29.11
29.58
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Tonix Pharma (TNXP) Moving Averages

Sep 22, 2025, 03:46 AM
Period
Simple
Exponential
MA5
27.39Sell
27.32Sell
MA10
27.49Sell
27.94Sell
MA20
29.11Sell
30.34Sell
MA50
38.83Sell
34.34Sell
MA100
35.04Sell
33.38Sell
MA200
28.49Sell
28.58Sell
Tonix Pharma’s (TNXP) 10-Day exponential moving average is 27.94, while Tonix Pharma’s (TNXP) share price is $26, making it a Sell.
Tonix Pharma’s (TNXP) 100-Day exponential moving average is 33.38, while Tonix Pharma’s (TNXP) share price is $26, making it a Sell.
Tonix Pharma’s (TNXP) stock price is $26 and Tonix Pharma’s (TNXP) 50-day simple moving average is 38.83, creating a Sell signal.
Tonix Pharma’s (TNXP) stock price is $26 and Tonix Pharma’s (TNXP) 100-day simple moving average is 35.04, creating a Sell signal.
Tonix Pharma’s (TNXP) stock price is $26 and Tonix Pharma’s (TNXP) 200-day simple moving average is 28.49, creating a Sell signal.

Tonix Pharma (TNXP) Technical Indicators

Sep 22, 2025, 03:46 AM
Name
Value
Implied Action
RSI (14)
37.61
Neutral
STOCH (9,6)
42.99
Neutral
STOCHRSI (14)
40.05
Neutral
MACD (12,26)
-3.37
Sell
ADX (14)
14.44
Buy
Williams %R
-75.51
Buy
CCI (14)
-63.19
Neutral
ATR (14)
3.18
-
Ultimate Oscillator
41.89
Neutral
ROC
-12.25
Sell
Tonix Pharma’s (TNXP) Relative Strength Index (RSI) is 37.61, creating a Neutral signal.
Tonix Pharma’s (TNXP) Trend Strength Indicator (ADX) is 14.44, creating a Buy signal.
Tonix Pharma’s (TNXP) Commodity Channel Index (CCI) is -63.19, creating a Neutral signal.
Tonix Pharma’s (TNXP) Price Rate of Change (ROC) is -12.25, creating a Sell signal.

FAQ

Is TNXP a Buy, Hold, or Sell?
Based on TNXP’s technical indicators, TNXP is a Strong Sell.
    What is TNXP’s RSI (14)?
    TNXP’s RSI (14) is 37.61, which suggests TNXP is a Neutral.
      What is TNXP’s MACD?
      TNXP’s MACD is -3.37, which suggests TNXP is a Sell.
        What is TNXP’s 5-day moving average?
        TNXP’s 5-day moving average is 27.39, which suggests TNXP is a Sell.
          What is TNXP’s 20-day moving average?
          TNXP 20-day moving average is 29.11, which suggests TNXP is a Sell.
            What is TNXP’s 50-day moving average?
            TNXP’s 50-day moving average is 38.83, which suggests TNXP is a Sell.
              What is TNXP’s 200-day moving average?
              TNXP’s 200-day moving average is 28.49, which suggests TNXP is a Sell.
                What is TNXP’s Williams % R (14)?
                TNXP’s Williams % R (14) is -75.51, which suggests TNXP is a Buy.
                  What is TNXP’s CCI (14)?
                  TNXP’s CCI (14) is -63.19, which suggests TNXP is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis